Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024)
Biofrontera (BFRI) posted quarterly Change in Acquisitions & Divestments of $57000.0 for Q1 2024, down 10.94% quarter-over-quarter from $64000.0 in Q4 2023.
Biofrontera (BFRI) Change in Acquisitions & Divestments (2023 - 2024) Analysis & Trends
Biofrontera's Change in Acquisitions & Divestments history runs 2 years deep, the most recent figure standing at $57000.0 for Q1 2024.
- In Q1 2024, Change in Acquisitions & Divestments changed N/A year-over-year to $57000.0; the TTM figure through Dec 2024 stood at $57000.0 (changed N/A YoY), while the FY2024 annual figure was $57000.0, down 90.87% from the prior year.
- Change in Acquisitions & Divestments for Q1 2024 stood at $57000.0, down from $64000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $382000.0 in Q3 2023, with the low at $57000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 57,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Dec 31, 2023 | 64,000.00 |
| Sep 30, 2023 | 382,000.00 |
| Sep 30, 2023 | 382,000.00 |